Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
TypePermanentWorking TypeOn siteAvailable for SecondmentNoClosing Date04-May-2026JD_Param11YesJD_Param12Yes The UCL Ear Institute The UCL Ear Institute is a world-leading international centre for research and teaching
-
UCL Careers provides careers education to current students, graduates and staff of UCL, as well as recruitment solutions for employers. UCL Careers provides a ‘core’ service for students as
-
UCL Laws At the heart of legal London, we attract the leading figures in the field to contribute to our vibrant programme of events, informing public debate and understanding of contemporary social
-
-termWorking TypeOn siteAvailable for SecondmentNoClosing Date17-May-2026JD_Param11YesJD_Param12Yes The UCL Queen Square Institute of Neurology (ION) in Queen Square was established in 1950, merged with UCL in
-
, and disease mechanisms. What We Offer Significant strategic investment and research support A collaborative environment across UCL and UCLH Opportunities to shape high‑impact, cross‑disciplinary
-
-£76,244Contract TypeFixed-termWorking TypeHybridAvailable for SecondmentNoClosing Date04-May-2026JD_Param11YesJD_Param12Yes The UCL Grand Challenges (GC) programme, led by RIGE, stimulates cross-disciplinary
-
translational environment of the UCL Institute of Neurology, the ARUK UDDI is uniquely placed to find novel targets, rapidly validate identified novel targets and mechanisms, establish screens and progress
-
About us University College London (UCL) is London’s leading multi-disciplinary university. UCL’s research and teaching is organised within 11 faculties, each housing a number of departments
-
TypeHybridAvailable for SecondmentNoClosing Date26-Apr-2026JD_Param11YesJD_Param12Yes UCL is one of the world’s leading universities, with more than 51,000 students, 18,000 staff and a total income exceeding £2bn. We
-
translational environment of the UCL Institute of Neurology, the ARUK UDDI is uniquely placed to find novel targets, rapidly validate identified novel targets and mechanisms, establish screens and progress